Overview:
The demand for contract manufacturing demand has increased as many of the pharmaceutical and biopharmaceutical companies are increasingly focusing on their respective core strengths to manage rising price pressure. However, vaccine manufacturing is a complex procedure, with effectiveness, safety, and sustainability being the most challenging parts for manufacturers. Vaccine contract manufacturing offer many services, such as construction and operation of manufacturing product, production process, process optimization, analytical characterization, cell line development, and fermentation, which in turn is expected to boost the growth of the global vaccine contract manufacturing market.
Get Sample Report with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-sample/1083
Drivers:
High incidence of various viral and bacterial infections worldwide is expected to augment the growth of the global vaccine contract manufacturing market during the forecast period. For instance, as reported by the World Health Organisation (WHO), over 3 to 5 million cases of severe illness and around 250,000 to 500,000 deaths due to influenza were registered in 2016.
Moreover, continuous research for the development of new vaccines and availability of funds for the same is expected to boost the growth of the global vaccine contract manufacturing market. For instance, in August 2017, the National Institute of Allergy and Infectious Diseases (NIAID) granted around US$ 2.5 million to Soligenix to develop bioterror vaccine to prevent the effects of ricin exposure.
BioMARK, a vaccine manufacturing facility of Colorado State University, received a fund of around US$ 3 million from U.S. Department of Defence (DoD) to develop a vaccine against a mosquito borne viral pathogen, which causes Venezuelan equine encephalitis (VEE).
Furthermore, in 2016, Emergent BioSolutions and Centres for Disease Control and Prevention (CDC) signed a contract worth US$ 911 million to develop and supply around 29 million doses of BioThrax anthrax vaccine in the next five years.
In March 2017, Goodwin Biotechnology Inc. and Minneapolis Medical Research Foundation (MMRF) signed a contract to develop/manufacture two vaccines for the treatment of opioid. While, in September 2017, Bavarian Nordic A/S and Biomedical Advanced Research and Development Authority (BARDA) signed a contract to manufacture and store freeze-dried IMVAMUNE smallpox vaccine.
Similarly, in September 2017, National Institute of Allergy and Infectious Diseases (NIAID) granted around US$ 2.6 million to Thomas Jefferson University to prepare and test vaccine against Marburg, Sudan, Ebola, and Lassa fever viruses.
Get PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/1083
Market Taxonomy:
By Service Type:
- Fill-Finish
- Bulk product
By Vaccine Type:
- Subunit Vaccines
- Live Attenuated Vaccines
- Conjugate Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
- Toxoid Vaccines
- Synthetic Vaccines
By Product Type:
- Single Vaccine
- Combination Vaccine
Key players:
Key players active in the global vaccine contract manufacturing market include BioMARK, Catalent Biologics, Emergent BioSolutions, FUJIFILM Diosynth Biotechnologies, Soligenix Inc., Minneapolis Medical Research Foundation (MMRF), Thomas Jefferson University, Bavarian Nordic A/S, and Goodwin Biotechnology Inc.
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/insight/buy-now/1083
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837